EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, LAB: Standard Biotools Inc

02 Apr 26 15:59
LAST:

0.9071

CHANGE:
 0.01		OPEN:
0.9300		HIGH:
0.9300		ASK:
0.0000		VOLUME:
1.23M
CHG(%):
1.13		PREV:
0.9183		LOW:
0.8817		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
02 Apr 260.90530.92890.88170.90791.65M
01 Apr 260.94000.94360.91660.91831.03M
31 Mar 260.94000.96000.91000.91931.87M
30 Mar 260.89000.92960.88000.92161.44M
27 Mar 260.95120.95820.89500.89732.48M
26 Mar 260.95500.98000.94940.95801.03M
25 Mar 260.95500.98320.94570.96201.23M
24 Mar 260.96490.97250.94480.9499906.1K
23 Mar 260.98951.01000.96040.97381.07M
20 Mar 260.95391.00500.95000.98463.78M

PROFILE

Name:Standard Biotools Inc
About:Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates in two segments, Proteomics and Genomics. Its proteomics and genomics include instruments, consumables, software, and services based upon technologies used in the identification of proteins, as well as genes and their functions. The company provides SomaScan platform that enables researchers to measure proteins simultaneously and provides deep insights into biological processes and disease mechanisms; CyTOF technology platform that uses metal-tagged antibodies and time-of-flight mass spectrometry to eliminate signal interference and expand multiplexing capabilities; Hyperion, a spatial biology platform, which unlocks deeper insights into tissue organization by preserving spatial context while enabling high-dimensional molecular and proteomic analysis; and Biomark X9 system that redefines high-throughput genomics for quantitative polymerase chain reaction applications. The company sells its instruments and consumables for research use only to academic research institutions, translational research and medicine centers, cancer centers, and clinical research laboratories, as well as biopharmaceutical, biotechnology, and plant and animal research companies. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Standard BioTools Inc. was incorporated in 1999 and is headquartered in South San Francisco, California.
Sector:Healthcare
Address:2 Tower Place, South San Francisco, CA, United States, 94080
Website:https://www.standardbio.com
CUSIP:34385P108
CIK:0001162194
ISIN:US34385P1084
FIGI:BBG000S8WQB6
LEI:549300GX8Y96GSB6YP89

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-2.38 
Forward P/E:-32.00 
PEG Ratio:0.10 
Price to Sales:2.69 
Price to Book:1.04 
Profit Margin:-0.70 
Operating Margin:-0.29 
Return on Assets:-0.14 
Return on Equity:-0.30 
EPS Ratio:-0.39 
Revenue:172.27M 
Shares:384.57M 
Market Cap:348.84M 

TECHNICAL INDICATORS

MA5:0.910.6%
MA10:0.943.5%
MA20:0.955.0%
MA50:1.1324.4%
MA100:1.2740.1%
MA200:1.2841.1%
STO9:9.41 
STO14:9.41 
RSI14:45.04
WPR14:-87.86 
MTM14:-0.05
ROC14:-0.05 
ATR:0.04 
Week High:0.988.0%
Week Low:0.883.1%
Month High:1.1729.0%
Month Low:0.8841.1%
Year High:1.7289.6%
Year Low:0.883.1%
Volatility:6.15